Payrits M, Sághy É, Mátyus P, Czompa A, Ludmerczki R, Deme R, Sándor Z, Helyes Zs, Szőke É
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Pécs, Pécs-7624, Szigeti str. 12., Hungary; Szentágothai Research Centre, University of Pécs, Pécs-7624, Ifjúság str. 20., Hungary.
Department of Organic Chemistry, University of Semmelweis, Budapest-1092, Hőgyes Endre str. 7., Hungary.
Neuroscience. 2016 Jun 2;324:151-62. doi: 10.1016/j.neuroscience.2016.02.049. Epub 2016 Feb 27.
Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1, TRPV1) ion channels expressed on nociceptive primary sensory neurons are important regulators of pain and inflammation. TRPA1 is activated by several inflammatory mediators including formaldehyde and methylglyoxal that are products of the semicarbazide-sensitive amine-oxidase enzyme (SSAO). SZV-1287 is a new 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime SSAO inhibitor, its chemical structure is similar to other oxime derivatives described as TRPA1 antagonists. Therefore, we investigated its effects on TRPA1 and TRPV1 receptor activation on the cell bodies and peripheral terminals of primary sensory neurons and TRPA1 or TRPV1 receptor-expressing cell lines. Calcium influx in response to the TRPA1 agonist allyl-isothiocyanate (AITC) (200 μM) and the TRPV1 stimulator capsaicin (330 nM) in rat trigeminal neurons or TRPA1 and TRPV1 receptor-expressing cell lines was measured by microfluorimetry or radioactive (45)Ca(2+) uptake experiments. Calcitonin gene-related peptide (CGRP) release as the indicator of 100 μM AITC - or 100 nM capsaicin-induced peripheral sensory nerve terminal activation was measured by radioimmunoassay. SZV-1287 (100, 500 and 1000 nM) exerted a concentration-dependent significant inhibition on both AITC- and capsaicin-evoked calcium influx in trigeminal neurons and TRPA1 or TRPV1 receptor-expressing cell lines. It also significantly inhibited the TRPA1, but not the TRPV1 activation-induced CGRP release from the peripheral sensory nerve endings in a concentration-dependent manner. In contrast, the reference SSAO inhibitor LJP 1207 with a different structure had no effect on TRPA1 or TRPV1 activation in either model system. This is the first evidence that our novel oxime compound SZV-1287 originally developed as a SSAO inhibitor has a potent dual antagonistic action on TRPA1 and TRPV1 ion channels on primary sensory neurons.
伤害性初级感觉神经元上表达的瞬时受体电位锚蛋白1和香草酸受体1(TRPA1、TRPV1)离子通道是疼痛和炎症的重要调节因子。TRPA1可被包括甲醛和甲基乙二醛在内的多种炎症介质激活,这些介质是氨基脲敏感胺氧化酶(SSAO)的产物。SZV-1287是一种新型的3-(4,5-二苯基-1,3-恶唑-2-基)丙醛肟SSAO抑制剂,其化学结构与其他被描述为TRPA1拮抗剂的肟衍生物相似。因此,我们研究了其对初级感觉神经元细胞体和外周终末以及表达TRPA1或TRPV1受体的细胞系上TRPA1和TRPV1受体激活的影响。通过微量荧光测定法或放射性(45)Ca(2+)摄取实验,检测大鼠三叉神经元或表达TRPA1和TRPV1受体的细胞系中,对TRPA1激动剂烯丙基异硫氰酸酯(AITC)(200μM)和TRPV1刺激剂辣椒素(330 nM)的钙内流情况。通过放射免疫测定法,检测降钙素基因相关肽(CGRP)的释放,以此作为100μM AITC或100 nM辣椒素诱导的外周感觉神经终末激活的指标。SZV-1287(100、500和1000 nM)对三叉神经元以及表达TRPA1或TRPV1受体的细胞系中AITC和辣椒素诱发的钙内流均产生浓度依赖性的显著抑制作用。它还以浓度依赖性方式显著抑制TRPA1激活诱导的外周感觉神经末梢CGRP释放,但对TRPV1激活诱导的CGRP释放无抑制作用。相比之下,结构不同的参考SSAO抑制剂LJP 1207在任一模型系统中对TRPA1或TRPV1激活均无影响。这是首个证据表明,我们最初作为SSAO抑制剂开发的新型肟化合物SZV-1287对初级感觉神经元上的TRPA1和TRPV1离子通道具有强效的双重拮抗作用。